Stay updated with breaking news from Scientific Program Committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Favorable safety profile, high overall response and complete response rates, and CAR T persistence observed in patients with relapsed or refractory follicular lymphoma
/PRNewswire/ -- Dr. Serhat Gumrukçu, inventor and co-founder of Enochian BioSciences and Director of Research at the Seraph Research Institute, was invited to...
LOS ANGELES, April 05, 2022.) Dr. Gumrukçu's scientific presentation focused on innovative clinical strategies he has designed to hyper-stimulate various components of the immune system, including
/PRNewswire/ -- During the March 2022 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), Mark Dresser, PhD, will accept...
ALEXANDRIA, Va., Feb. 16, 2022 /PRNewswire/ -- During the March 2022 Annual Meeting of the American Society for Clinical Pharmacology and Therapeu...